Cost-effectivness analysis of the antihypertensive therapy
Th e arterial hypertension oft en meets among the population of Mongolia and is one of principal causes of development of cardiovascular complications and death rates from them. Th e pharmacoeconomical analysis of treatment for artheriol hypertensive desease is done by method of Cost-Eff ectiveness according to, WHO (developed by Tan. Torres Edejer, R.Baltussen, T.Adam, R.Hutubessy, A.Acharya. D.B.Evans, C.J.L.Murray etc.). It is shown, that the combined treatment (inhibitors of Angiotensin converting enzyme + diuretic + -adrenoreceptor antagonist) was the most eff ective on a parameter Cost-effi ciency.